What is Ablatherm?
Ablatherm® HIFU is a procedure where the temperature inside the prostate is raised to 85° Celsius using a focused ultrasound beam. After spinal anesthesia with intravenous sedation the physician places a probe into the rectum. This probe emits a beam of high intensity focused ultrasound.
When was HIFU approved by FDA?
On November 27, 2020, the Food and Drug Administration approved the Sonalleve MR-HIFU system (Profound Medical Inc.) for the treatment of osteoid osteoma in the extremities.
How much does HIFU cost in Canada?
The procedure costs about $22,000, which must be paid out-of-pocket because HIFU is not covered by any provincial insurance plan in Canada.
Why is HIFU not covered by insurance?
We understand that HIFU is an expensive procedure. Unlike some other treatments for prostate cancer, it is not yet covered by insurance. That is because it typically takes about 5 years from FDA approval of a procedure to the time when insurers pay for it.
Is prostate ablation FDA approved?
Profound Medical recently announced that its TULSA-PRO® device has earned 510(k) clearance by the US Food and Drug Administration (FDA) to ablate prostate tissue. TULSA-PRO is the first transurethral ultrasound device to earn FDA approval for the ablation of prostate tissue.
Does HIFU work on prostate?
HIFU destroys prostate cancer through the delivery of precise and focused sound waves to a targeted spot of diseased prostate tissue. This technology uses ultrasound energy, not radiation, to destroy the targeted tissue.
How much does HIFU prostate treatment cost?
The treatment can range in cost from $15,000 to $25,000. HIFU is the latest treatment to prompt concerns over whether there should be limits — such as requiring tracking of results — placed on expensive new technology while additional data is gathered.
Does insurance cover HIFU 2021?
For virtually all patients, there is typically no coverage by commercial health insurers, or Medicare for HIFU at this time.
Is focal laser ablation covered by Medicare?
This procedure is not covered by Medicare or by any major insurance carriers, MRI Focal Laser Ablation can be considered for very small discrete tumors in the prostate that are well visualized by MRI.
Is TULSA FDA approved?
TULSA received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market TULSA-PRO® for ablation of prostate tissue in August of 2019. The FDA’s clearance of TULSA-PRO® was based on the Company’s TACT pivotal clinical trial, which met all of its primary and secondary efficacy and safety endpoints.
